Literature DB >> 2549070

Carboxypeptidase H. A regulatory peptide-processing enzyme produced by human hepatoma Hep G2 cells.

B G Grimwood1, T H Plummer, A L Tarentino.   

Abstract

Human hepatoma (Hep G2) cells have been shown to secrete nanogram quantities of carboxypeptidase N (Grimwood, B. G., Plummer, T. H., Jr., and Tarentino, A. (1988) J. Biol. Chem. 263, 14397-14401). A second carboxypeptidase with an acidic pH optimum (pH 5.5) is also secreted at levels 2-3-fold greater than carboxypeptidase N. This enzyme was partially purified from the conditioned medium and compared with pure bovine pituitary carboxypeptidase H. The two enzymes behaved in a similar fashion in DE52 ion-exchange chromatography and on gel filtration, with the Hep G2 enzyme being slightly larger than the bovine pituitary enzyme (52-54 versus 50-52 kDa). Both enzymes hydrolyzed COOH-terminal basic amino acids from typical synthetic substrates as well as from natural leuenkephalin peptides and were identical based on pH activity profiles, inhibition by EDTA or guanidinoethyl mercaptosuccinic acid, and stimulation by Co2+ ions. Inhibition of enzyme secretion from Hep G2 cells by tunicamycin indicated that the Hep G2 enzyme was glycosylated. This finding was confirmed by a parallel deglycosylation of the Hep G2 and bovine pituitary carboxypeptidase H enzymes with peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase F. Immunoblots using mouse antiserum to bovine pituitary carboxypeptidase H revealed that the Hep G2 enzyme was immunocross-reactive with the bovine enzyme but was slightly larger in size (54 versus 52 kDa). Continuous [35S]methionine labeling and purification to near homogeneity using an affinity matrix corroborated the observations that the secreted Hep G2 carboxypeptidase H was slightly larger than bovine pituitary carboxypeptidase H. The Hep G2-secreted enzyme in pulse-chase experiments was initially detected intracellularly after a 15-min pulse as a single protein of about 54 kDa and was present in the 30-min chase medium with no evidence for pre- or postsecretion proteolytic processing. The human adrenergic cell line IMR-32 continuously labeled with [35S]methionine also secreted carboxypeptidase H of the same size as the Hep G2 enzyme.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2549070

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  An N-terminal truncated carboxypeptidase E splice isoform induces tumor growth and is a biomarker for predicting future metastasis in human cancers.

Authors:  Terence K Lee; Saravana R K Murthy; Niamh X Cawley; Savita Dhanvantari; Stephen M Hewitt; Hong Lou; Tracy Lau; Stephanie Ma; Thanh Huynh; Robert A Wesley; Irene O Ng; Karel Pacak; Ronnie T Poon; Y Peng Loh
Journal:  J Clin Invest       Date:  2011-03       Impact factor: 14.808

2.  Sequence of human carboxypeptidase D reveals it to be a member of the regulatory carboxypeptidase family with three tandem active site domains.

Authors:  F Tan; M Rehli; S W Krause; R A Skidgel
Journal:  Biochem J       Date:  1997-10-01       Impact factor: 3.857

3.  Carboxypeptidase E: elevated expression correlated with tumor growth and metastasis in pheochromocytomas and other cancers.

Authors:  Saravana R K Murthy; Karel Pacak; Y Peng Loh
Journal:  Cell Mol Neurobiol       Date:  2010-11       Impact factor: 5.046

Review 4.  Carboxypeptidase E and its splice variants: Key regulators of growth and metastasis in multiple cancer types.

Authors:  Sangeetha Hareendran; Xuyu Yang; Vinay Kumar Sharma; Y Peng Loh
Journal:  Cancer Lett       Date:  2022-08-18       Impact factor: 9.756

5.  Processing and secretion of human carboxypeptidase E by C6 glioma cells.

Authors:  E Manser; D Fernandez; L Lim
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

6.  Carboxypeptidase E-∆N Promotes Proliferation and Invasion of Pancreatic Cancer Cells via Upregulation of CXCR2 Gene Expression.

Authors:  Sangeetha Hareendran; Xuyu Yang; Hong Lou; Lan Xiao; Y Peng Loh
Journal:  Int J Mol Sci       Date:  2019-11-15       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.